Literature DB >> 28439650

Gadoxetic acid disodium-enhanced MR imaging of cholangiolocellular carcinoma of the liver: imaging characteristics and histopathological correlations.

Hiroki Haradome1, Toshiyuki Unno2, Hiroyuki Morisaka3, Yusuke Toda4, Thomas C Kwee5, Hiroshi Kondo6, Keiji Sano7, Tomoaki Ichikawa3, Fukuo Kondo8, Masahiko Sugitani9, Tadatoshi Takayama10.   

Abstract

OBJECTIVES: To review the gadoxetic acid disodium (EOB)-enhanced magnetic resonance (MR) imaging features of cholangiolocellular carcinoma (CoCC) of the liver and compare them with those of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC).
METHODS: EOB-enhanced MR images of 19 patients with CoCC, 23 with ICC, and 51 with HCC were retrospectively evaluated qualitatively and quantitatively. Univariate and multivariate analyses were performed to determine the characteristic MR features of CoCC with histopathological-imaging correlation.
RESULTS: Multivariate logistic regression analysis showed that dot-/band-shaped internal enhancement during the arterial and portal phases (P < 0.001), and larger arterial ring enhancement ratio (CoCC, 0.13 ± 0.04; ICC, 0.074 ± 0.04; P = 0.013) were significantly independently associated with CoCC in contrast to ICC, whereas several MR features including progressive enhancement during the portal and late phases (P < 0.001), target appearance in the hepatocyte phase (P = 0.004), and vessel penetration (P = 0.013) were significantly more frequently associated with CoCC than HCC. The dot-/band-like internal enhancement (78.9% of CoCCs) histopathologically corresponded to the tumour cell nest with vascular proliferations and retained Glisson's sheath structure.
CONCLUSIONS: EOB-enhanced MR features of CoCC largely differ from those of HCC but are similar to those of ICC. However, the finding of thicker arterial ring enhancement with dot-/band-like internal enhancement could help differentiate CoCC from ICC. KEY POINTS: • Gadoxetic acid-enhanced MR features of cholangiolocellular carcinoma (CoCC) resembled those of intrahepatic cholangiocarcinoma (ICC). • Gadoxetic acid-enhanced MR features of CoCC largely differed from those of hepatocellular carcinoma. • Dot-/band-like internal enhancement of CoCC may be helpful for differentiating from ICC. • Arterial ring enhancement of CoCC was larger than that of ICC.

Entities:  

Keywords:  Cholangiolocellular carcinoma; Gadoxetic acid disodium-enhanced magnetic resonance imaging; Hepatocellular carcinoma; Intrahepatic cholangiocarcinoma; Liver

Mesh:

Substances:

Year:  2017        PMID: 28439650     DOI: 10.1007/s00330-017-4811-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  23 in total

1.  Cholangiolocellular carcinoma of the liver: CT and MR findings.

Authors:  Y Fukukura; M Hamanoue; F Fujiyoshi; M Sasaki; K Haruta; H Inoue; T Aiko; M Nakajo
Journal:  J Comput Assist Tomogr       Date:  2000 Sep-Oct       Impact factor: 1.826

Review 2.  Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI.

Authors:  Stefano Palmucci
Journal:  World J Hepatol       Date:  2014-07-27

3.  Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI.

Authors:  Jieun Koh; Yong Eun Chung; Ji Hae Nahm; Ha Yan Kim; Kyung-Sik Kim; Young Nyun Park; Myeong-Jin Kim; Jin-Young Choi
Journal:  Eur Radiol       Date:  2015-05-23       Impact factor: 5.315

4.  Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation.

Authors:  Hyeon Tae Jeong; Myeong-Jin Kim; Yong Eun Chung; Jin Young Choi; Young Nyun Park; Ki Whang Kim
Journal:  AJR Am J Roentgenol       Date:  2013-10       Impact factor: 3.959

5.  The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging.

Authors:  Vincenza Granata; Orlando Catalano; Roberta Fusco; Fabiana Tatangelo; Daniela Rega; Guglielmo Nasti; Antonio Avallone; Mauro Piccirillo; Francesco Izzo; Antonella Petrillo
Journal:  Abdom Imaging       Date:  2015-10

Review 6.  Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging--A Systematic Review.

Authors:  Matthew D F McInnes; Rebecca M Hibbert; João R Inácio; Nicola Schieda
Journal:  Radiology       Date:  2015-05-26       Impact factor: 11.105

7.  Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.

Authors:  Sung Soo Ahn; Myeong-Jin Kim; Joon Seok Lim; Hye-Suk Hong; Yong Eun Chung; Jin-Young Choi
Journal:  Radiology       Date:  2010-05       Impact factor: 11.105

8.  Imaging of cholangiolocellular carcinoma of the liver.

Authors:  Yoshiki Asayama; Tsuyoshi Tajima; Daisuke Okamoto; Akihiro Nishie; Kousei Ishigami; Yasuhiro Ushijima; Daisuke Kakihara; Shinichi Aishima; Akinobu Taketomi; Hiroshi Honda
Journal:  Eur J Radiol       Date:  2009-09-24       Impact factor: 3.528

9.  ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents.

Authors:  E Neri; M A Bali; A Ba-Ssalamah; P Boraschi; G Brancatelli; F Caseiro Alves; L Grazioli; T Helmberger; J M Lee; R Manfredi; L Martì-Bonmatì; C Matos; E M Merkle; B Op De Beeck; W Schima; S Skehan; V Vilgrain; C Zech; C Bartolozzi
Journal:  Eur Radiol       Date:  2015-07-21       Impact factor: 5.315

10.  Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging.

Authors:  Elmar M Merkle; Christoph J Zech; Carlo Bartolozzi; Mustafa R Bashir; Ahmed Ba-Ssalamah; Alexander Huppertz; Jeong Min Lee; Jens Ricke; Michiie Sakamoto; Claude B Sirlin; Sheng-Long Ye; Mengsu Zeng
Journal:  Eur Radiol       Date:  2015-06-13       Impact factor: 5.315

View more
  11 in total

1.  A New Diagnostic Criterion with Gadoxetic Acid-Enhanced MRI May Improve the Diagnostic Performance for Hepatocellular Carcinoma.

Authors:  Yi Wei; Zheng Ye; Yuan Yuan; Zixing Huang; Xiaocheng Wei; Tong Zhang; Shang Wan; Hehan Tang; Xiaopeng He; Bin Song
Journal:  Liver Cancer       Date:  2020-04-14       Impact factor: 11.740

2.  Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.

Authors:  Jordi Rimola; Alejandro Forner; Víctor Sapena; Neus Llarch; Anna Darnell; Alba Díaz; Angeles García-Criado; Lluís Bianchi; Ramon Vilana; Álvaro Díaz-González; Carmen Ayuso; Jordi Bruix; María Reig
Journal:  Eur Radiol       Date:  2019-08-01       Impact factor: 5.315

3.  Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.

Authors:  Seo-Youn Choi; Young Kon Kim; Ji Hye Min; Tae Wook Kang; Woo Kyoung Jeong; Soohyun Ahn; Hojeong Won
Journal:  Eur Radiol       Date:  2018-01-15       Impact factor: 5.315

4.  Inter-observer agreement of computed tomography and magnetic resonance imaging on gross tumor volume delineation of intrahepatic cholangiocarcinoma: an initial study.

Authors:  Nan Zhou; Anning Hu; Zhihao Shi; Xiaolu Wang; Qiongjie Zhu; Qun Zhou; Jun Ma; Feng Zhao; Weiwei Kong; Jian He
Journal:  Quant Imaging Med Surg       Date:  2021-02

5.  MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma.

Authors:  Xijuan Ma; Liheng Liu; Jun Fang; Shengxiang Rao; Lulu Lv; Mengsu Zeng; Yibing Shi; Chun Yang
Journal:  Cancer Imaging       Date:  2020-06-23       Impact factor: 3.909

Review 6.  Combined Hepatocellular-Cholangiocarcinoma: Changes in the 2019 World Health Organization Histological Classification System and Potential Impact on Imaging-Based Diagnosis.

Authors:  Tae Hyung Kim; Haeryoung Kim; Ijin Joo; Jeong Min Lee
Journal:  Korean J Radiol       Date:  2020-07-27       Impact factor: 3.500

7.  Optimal Combination of Features on Gadoxetate Disodium-enhanced MR Imaging for Non-invasive Differential Diagnosis of Hepatocellular Carcinoma: The JAMP-HCC Study.

Authors:  Shintaro Ichikawa; Utaroh Motosugi; Hiroyuki Morisaka; Kazuto Kozaka; Satoshi Goshima; Tomoaki Ichikawa
Journal:  Magn Reson Med Sci       Date:  2020-02-27       Impact factor: 2.471

8.  A Multi-Parametric Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion Status in Intrahepatic Cholangiocarcinoma.

Authors:  Xianling Qian; Xin Lu; Xijuan Ma; Ying Zhang; Changwu Zhou; Fang Wang; Yibing Shi; Mengsu Zeng
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

Review 9.  Gadoxetic acid magnetic-enhanced resonance imaging in the diagnosis of cholangiocarcinoma.

Authors:  Riccardo Inchingolo; Cesare Maino; Marco Gatti; Eleonora Tricarico; Michele Nardella; Luigi Grazioli; Sandro Sironi; Davide Ippolito; Riccardo Faletti
Journal:  World J Gastroenterol       Date:  2020-08-07       Impact factor: 5.742

10.  Successfully Treated Case of Cholangiolocellular Carcinoma with a Poor Hepatic Functional Reserve Reporting with Various Imaging Findings.

Authors:  Satoshi Takakusagi; Yozo Yokoyama; Kazuko Kizawa; Kyoko Marubashi; Takashi Kosone; Ken Sato; Satoru Kakizaki; Kenichi Harada; Hitoshi Takagi; Toshio Uraoka
Journal:  Intern Med       Date:  2020-10-14       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.